These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31691056)

  • 41. [Significance of chemokine receptor CXCR3 expression in breast cancer].
    Li L; Chen J; Lu ZH; Yu SN; Luo YF; Zhao WG; Ma YH; Jia CW
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):85-8. PubMed ID: 21426802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
    Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
    J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients.
    Razmkhah M; Jaberipour M; Safaei A; Talei AR; Erfani N; Ghaderi A
    Eur Cytokine Netw; 2012; 23(3):72-7. PubMed ID: 23078970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Significant association between high serum CCL5 levels and better disease-free survival of patients with early breast cancer.
    Fujimoto Y; Inoue N; Morimoto K; Watanabe T; Hirota S; Imamura M; Matsushita Y; Katagiri T; Okamura H; Miyoshi Y
    Cancer Sci; 2020 Jan; 111(1):209-218. PubMed ID: 31724785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer.
    Zhang Q; Qin J; Zhong L; Gong L; Zhang B; Zhang Y; Gao WQ
    Cancer Res; 2015 Oct; 75(20):4312-21. PubMed ID: 26249173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer.
    Liao SC; Li JX; Yu L; Sun SR
    J Zhejiang Univ Sci B; 2017 Apr.; 18(4):334-342. PubMed ID: 28378571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7.
    Haghshenas MR; Ashraf MJ; Khademi B; Ghaderi A; Erfani N; Razmkhah M
    Eur Cytokine Netw; 2017 Mar; 28(1):27-35. PubMed ID: 28840842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma CCL5 promotes EMT-medicated epirubicin-resistance in locally advanced breast cancer.
    Ma G; Huang H; Li M; Li L; Kong P; Zhu Y; Xia T; Wang S
    Cancer Biomark; 2018; 22(3):405-415. PubMed ID: 29758926
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer.
    Khalid A; Wolfram J; Ferrari I; Mu C; Mai J; Yang Z; Zhao Y; Ferrari M; Ma X; Shen H
    Mini Rev Med Chem; 2015; 15(13):1063-72. PubMed ID: 26420723
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CCL5 activation of CCR5 regulates cell metabolism to enhance proliferation of breast cancer cells.
    Gao D; Rahbar R; Fish EN
    Open Biol; 2016 Jun; 6(6):. PubMed ID: 27335323
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naming the Barriers between Anti-CCR5 Therapy, Breast Cancer and Its Microenvironment.
    Brett E; Duscher D; Pagani A; Daigeler A; Kolbenschlag J; Hahn M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430633
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C-C chemokine hepatocellular carcinoma motif ligand 5-deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment.
    Li X; Han QC; Yu C; Luo YC; Wang F; Sun XH; Gao YQ; Tan WF; Xia Q
    J Dig Dis; 2021 Jul; 22(7):433-441. PubMed ID: 33978316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer.
    Ding H; Zhao L; Dai S; Li L; Wang F; Shan B
    Biomed Pharmacother; 2016 Feb; 77():142-9. PubMed ID: 26796278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression and clinical significance of CCL5 in patients with esophageal carcinoma].
    Liu J; Li F; Chen X; Wang L; Yue D; Zhao S; Hu W; Kalinski P; Thorne S; Hou J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Nov; 36(11):828-33. PubMed ID: 25620479
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
    Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
    Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Down-regulation of KLF5 in cancer-associated fibroblasts inhibit gastric cancer cells progression by CCL5/CCR5 axis.
    Yang T; Chen M; Yang X; Zhang X; Zhang Z; Sun Y; Xu B; Hua J; He Z; Song Z
    Cancer Biol Ther; 2017 Oct; 18(10):806-815. PubMed ID: 28934010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.
    Liu J; Li F; Ping Y; Wang L; Chen X; Wang D; Cao L; Zhao S; Li B; Kalinski P; Thorne SH; Zhang B; Zhang Y
    Oncotarget; 2015 Sep; 6(28):24978-89. PubMed ID: 26317795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans.
    Soria G; Lebel-Haziv Y; Ehrlich M; Meshel T; Suez A; Avezov E; Rozenberg P; Ben-Baruch A
    Neoplasia; 2012 Jan; 14(1):1-19. PubMed ID: 22355269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
    Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
    Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.